Effectiveness of Using an Oil Bath Additive
Prospective, Randomized Study on the Skin Functional Parameters to Assess Skin Barrier Improvement After the Use of a Commercially Available Oil Bath Containing 84.75% Soybean Oil Compared to no Bath Additive
1 other identifier
interventional
60
1 country
1
Brief Summary
Epidermis that lacks moisture and/or sebum presents as dry skin, which is often characterized by a pattern of fine lines, scaling and itching. In dry skin, the barrier function may be compromised. Skin care practices to decrease the risk of development of dry skin and/or to improve dry skin condition have barely been investigated. Bathing with bath oils has been shown to increase skin hydration, thus helping to stabilize skin barrier function. Therefore, the aim of this study is to investigate the effect of bathing every other day on the skin barrier. Functional parameters, such as TEWL, stratum corneum hydration (SCH) and skin-pH (pH) were measured to characterize skin barrier function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2014
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2015
CompletedFirst Submitted
Initial submission to the registry
September 21, 2015
CompletedFirst Posted
Study publicly available on registry
September 23, 2015
CompletedResults Posted
Study results publicly available
March 7, 2017
CompletedApril 5, 2017
March 1, 2017
5 months
September 21, 2015
January 18, 2017
March 7, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Transepidermal Water Loss (TEWL) in g/m2/h at the Left Mid Volar Forearm
TEWL was measured using the Tewameter TM300 (Courage+Khazaka, Cologne, Germany) according to international guidelines (Rogiers 2001). This open chamber intrument measured water evaporation from the skin by temperature and humidity sensors inside the cylinder. Means of triple measurements per skin area in g/m2/h on the left midvolar forearm. Visit 3 (day 28) - end of study visit
Day 28 +/- 3
Secondary Outcomes (29)
Transepidermal Water Loss (TEWL) in g/m2/h at the Left Mid Volar Forearm
Day 14 +/- 2
Transepidermal Water Loss (TEWL) in g/m2/h at the Right Lateral Lower Leg
Day 14 +/- 2
Transepidermal Water Loss (TEWL) in g/m2/h at the Right Lateral Lower Leg
Day 28 +/- 3
Stratum Corneum Hydration (SCH) in Arbitrary Units at the Right Lateral Lower Leg
Day 14 +/- 2
Stratum Corneum Hydration (SCH) in Arbitrary Units at the Right Lateral Lower Leg
Day 28 +/- 3
- +24 more secondary outcomes
Study Arms (2)
Balneum oil bath
EXPERIMENTALBalneum oil bath, bathing every other day for four weeks
standard skin cleanser
NO INTERVENTIONUsual skin cleanser (non-oil containing), bathing or showering every other day for four weeks
Interventions
Eligibility Criteria
You may qualify if:
- Signed informed consent, or children whose parent(s) or guardian(s) have given their written informed consent for their child's participation in the study
- Child specific written informed consent, if over 7 years of age
- Subjects with a general good and stable health condition
- Subjects with clinically stable medical conditions
- Accept to abstain from sunbathing and solarium during the study
- Overall Dry Skin score (ODS) of 1 to 2 at arms and lower legs
- TEWL \> 12 g/m2/h on the left mid volar forearm
You may not qualify if:
- Any dermatological condition or skin affection which may interfere with the study assessments, e.g. scars
- Suffering from porphyria
- Suffering from severe photodermatoses according to the judgment of the investigator
- Clinically significant, possibly unstable medical conditions such as metastatic tumor
- Currently having other malignant or benign tumors of the skin in the investigational area
- Any other acute or chronic pathology that may interfere with the study conduct in the investigator's opinion
- Known allergy or intolerance to any ingredients of the study product, e.g. propylene glycol
- Use of (medical) oil-containing bath additives or other oil-containing cleansers
- Current topical or systemic treatment affecting the skin, e.g. diuretics
- Systemic immunosuppressive or immunomodulatory therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Charité - Universitätsmedizin Berlin
Berlin, 10117, Germany
Related Publications (1)
Kottner J, Kanti V, Dobos G, Hahnel E, Lichterfeld-Kottner A, Richter C, Hillmann K, Vogt A, Blume-Peytavi U. The effectiveness of using a bath oil to reduce signs of dry skin: A randomized controlled pragmatic study. Int J Nurs Stud. 2017 Jan;65:17-24. doi: 10.1016/j.ijnurstu.2016.10.010. Epub 2016 Oct 26.
PMID: 27815985DERIVED
Results Point of Contact
- Title
- Dr. Jan Kottner
- Organization
- Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergology Charité - Universitätsmedizin Berlin
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Scientific Director Clinical Research Center for Hair and Skin Science
Study Record Dates
First Submitted
September 21, 2015
First Posted
September 23, 2015
Study Start
November 1, 2014
Primary Completion
April 1, 2015
Study Completion
September 1, 2015
Last Updated
April 5, 2017
Results First Posted
March 7, 2017
Record last verified: 2017-03